InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Rosol Michael Stanley, Directeur Médical. Director active across 1 company, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 2 reports have been published. Activity tracked since 14 January 2022. The latest transaction was filed on 9 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rosol Michael Stanley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
28,150 shares0Common StockSEC:0001437749-22-022307:0
7,728 shares0Common StockSEC:0001437749-22-001026:0
2 of 2 declarations
About Rosol Michael Stanley
Rosol Michael Stanley is the Chief Medical Officer at NAVIDEA BIOPHARMACEUTICALS, INC. He oversees the company's medical and research initiatives, ensuring that projects meet the highest standards. His expertise is crucial for the development of new therapies.
